Embecta Corp. provided earnings guidance for the fiscal year 2024. For the year, the company expects revenues to be $1,111 million -$1,116 million against previous guidance of $1,094 million- $1,116 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.44 USD | -2.89% | +0.57% | -34.28% |
May. 16 | Transcript : Embecta Corp. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM | |
May. 09 | Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.28% | 717M | |
-2.26% | 187B | |
+2.05% | 110B | |
-1.31% | 69.54B | |
+14.65% | 46.37B | |
-6.69% | 46.05B | |
+7.97% | 42.54B | |
+18.60% | 30.72B | |
-6.87% | 23.32B | |
-10.63% | 22.92B |
- Stock Market
- Equities
- EMBC Stock
- News Embecta Corp.
- Embecta Corp. Provides Earnings Guidance for the Fiscal Year 2024